Skip to Content »

Site Map

FREE Shipping: All Individuals in United States, Mexico, Central and South America & The Caribbean

Take 25 percent off your entire order.


* 25% off Holiday Sale: offer valid 11/26/15-1/04/2016. Only valid for purchases by individual U.S., Mexico, Central & South America and Caribbean customers at Current prices and offers subject to change without notice. Offers are not valid on Institutional Video Series, HESI Products, Kindle or Nook e-books, mobile apps, medical clothing or accessories or previous purchases. Offers cannot be combined with each other. Enter promotional code BBV2E16515 at checkout to receive your discount. This offer expires on January 4, 2016.

Myelodysplastic Syndromes, An Issue of Hematology/Oncology Clinics of North America

$99.00 $74.25

This book may take up to 5 business days to ship

Major strides have been made in the treatment and understanding of Myelodysplasia.  The United States Food and Drug Administration (FDA) has approved three new drugs for the treatment of MDS; new disease genes have been discovered; major insights have been made into the biology of the disorder; and animal models of MDS have been developed.  The articles in this issue illustrate the rapid progress in MDS research, from molecular pathophysiology to improved therapies.  Insights into the biology of MDS, the development of model systems to study MDS, and the application of new technologies with unprecedented power to interrogate the cancer genome promise to increase the rate of discovery, transforming our understanding of MDS and leading to improvements in the treatment this disease.

View other titles in the “ The Clinics: Internal Medicine” Series

View all Oncology titles

Author Information

    By Benjamin L. Ebert, MD, PhD

Customer Reviews

Myelodysplastic Syndromes, An Issue of Hematology/Oncology Clinics of North America
25% off
  • Hardcover
  • Reference
  • Imprint: Saunders
  • ISBN: 978-1-4377-2203-1
  • Copyright: 2010